Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q2 2026)
1,708
Value
$57.0K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of RARE by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,708$57.0K<0.1%+83+5.1%AddedHolders
Q1 20261,625$34.0K<0.1%+1,440+778.4%AddedHolders
Q4 2025185$4.25K<0.1%+31+20.1%AddedHolders
Q3 2025154$4.63K<0.1%−578−79.0%ReducedHolders
Q2 2025732$26.6K<0.1%+669+1,061.9%AddedHolders
Q1 202563$2.28K<0.1%−162−72.0%ReducedHolders
Q4 2024225$9.47K<0.1%−294−56.6%ReducedHolders
Q3 2024519$28.8K<0.1%+308+146.0%AddedHolders
Q2 2024211$8.67K<0.1%+143+210.3%AddedHolders
Q1 202468$3.17K<0.1%+37+119.4%AddedHolders
Q4 202331$1.48K<0.1%−238−88.5%ReducedHolders
Q3 2023269$9.59K<0.1%−175−39.4%ReducedHolders
Q2 2023444$20.5K<0.1%+303+214.9%AddedHolders
Q1 2023141$5.65K<0.1%−194−57.9%ReducedHolders
Q4 2022335$15.5K<0.1%+221+193.9%AddedHolders
Q3 2022114$5.00K<0.1%+17+17.5%AddedHolders
Q2 202297$6.00K<0.1%+42+76.4%AddedHolders
Q1 202255$4.00K<0.1%−34−38.2%ReducedHolders
Q4 202189$7.00K<0.1%+84+1,680.0%AddedHolders
Q3 20215$00.0%+5NewHolders
Q2 20210$00.0%−7−100.0%Sold outHolders
Q1 20217$1.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.